ABIGAIL BOGAN: Open Payments
NPI 1174304042 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 92 payments from 18 companies in 2025. Trend: 2023 $127 · 2024 $1,729 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $456 |
| PFIZER INC. | 16 | $278 |
| Inspire Medical Systems, Inc. | 2 | $184 |
| Lilly USA, LLC | 6 | $101 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Novo Nordisk Inc | 6 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| Amgen Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Corcept Therapeutics | 2 | $58 |
Products named: VRAYLAR, INSPIRE, QULIPTA, NURTEC ODT, UBRELVY, AIRSUPRA, Ozempic, Kerendia.
Industry payments across LA — which companies pay providers there.
